| P2093 | author name string | Gaylen L Edwards | |
| | Kimberly G Freeman | |
| | Juliane R Johnston | |
| P2860 | cites work | Cannabinoids and the Digestive Tract | Q22252841 |
| | CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology | Q28137628 |
| | Cannabinoids and the gut: new developments and emerging concepts | Q28271862 |
| | Identification and functional characterization of brainstem cannabinoid CB2 receptors | Q28276972 |
| | Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors | Q28292914 |
| | Cocaine- and amphetamine-regulated transcript: stimulation of expression in rat vagal afferent neurons by cholecystokinin and suppression by ghrelin | Q28292978 |
| | Molecular characterization of a peripheral receptor for cannabinoids | Q28298338 |
| | Cannabinoids and the gastrointestinal tract | Q28365382 |
| | Isolation and structure of a brain constituent that binds to the cannabinoid receptor | Q29547476 |
| | Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study | Q29615905 |
| | Determination and characterization of a cannabinoid receptor in rat brain | Q29618888 |
| | Bugs, guts and brains, and the regulation of food intake and body weight | Q33838142 |
| | Functional and chemical anatomy of the afferent vagal system | Q33934014 |
| | Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype | Q33994763 |
| | The endocannabinoid system links gut microbiota to adipogenesis | Q34078880 |
| | Vagal afferent pathway mediates physiological action of cholecystokinin on pancreatic enzyme secretion | Q34113980 |
| | Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists | Q34453695 |
| | The gastrointestinal pharmacology of cannabinoids. | Q34471097 |
| | Cholecystokinin: a putative satiety signal | Q67386142 |
| | Cholecystokinin as satiety signal | Q70197051 |
| | Vago‐vagal reflex effects on gastric and pancreatic secretion and gastro‐intestinal motility | Q78759003 |
| | Neuroendocrine control of food intake | Q80151225 |
| | Endocannabinoids in Body Weight Control | Q88924595 |
| | A hunger for hunger: a review of palliative therapies for cancer-associated anorexia | Q88962837 |
| | Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 |
| | Ghrelin-induced activation of cAMP signal transduction and its negative regulation by endocannabinoids in the hippocampus | Q34634438 |
| | Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance | Q34673072 |
| | Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system | Q34745063 |
| | Abdominal vagal afferent neurones: an important target for the treatment of gastrointestinal dysfunction | Q35026102 |
| | Gastrointestinal regulation of food intake | Q35251043 |
| | Involvement of cannabinoid receptors in gut motility and visceral perception | Q35752224 |
| | Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-Tetrahydrocannabinol | Q35860227 |
| | A centenary of gastrointestinal endocrinology | Q36012458 |
| | Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands. | Q36075529 |
| | Brainstem circuits regulating gastric function | Q36387897 |
| | Comparison of baroreceptive to other afferent synaptic transmission to the medial solitary tract nucleus. | Q37038928 |
| | The endogenous cannabinoid system protects against colonic inflammation | Q37370275 |
| | Vagal afferent neurons in high fat diet-induced obesity; intestinal microflora, gut inflammation and cholecystokinin | Q37849882 |
| | Physiological and psychosocial age-related changes associated with reduced food intake in older persons. | Q38043131 |
| | Cholecystokinin increases cytosolic calcium in a subpopulation of cultured vagal afferent neurons | Q40626472 |
| | Cholecystokinin and control of food intake | Q40691236 |
| | Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation | Q40757331 |
| | Anorexia during acute and chronic disease | Q41047136 |
| | High fat diet and body weight have different effects on cannabinoid CB(1) receptor expression in rat nodose ganglia | Q42091620 |
| | Localization of cannabinoid receptor mRNA in rat brain | Q42510202 |
| | Mice lacking cannabinoid CB1-, CB2-receptors or both receptors show increased susceptibility to trinitrobenzene sulfonic acid (TNBS)-induced colitis | Q43130152 |
| | Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin. | Q44804052 |
| | Gut bacteria interaction with vagal afferents | Q47845159 |
| | Brainstem pathways responsible for oesophageal control of gastric motility and tone in the rat. | Q48329815 |
| | Occipital artery injections of 5-HT may directly activate the cell bodies of vagal and glossopharyngeal afferent cell bodies in the rat. | Q48400721 |
| | Localization of mGluR5, GABAB, GABAA, and cannabinoid receptors on the vago-vagal reflex pathway responsible for transient lower esophageal sphincter relaxation in humans: an immunohistochemical study | Q48704972 |
| | Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum | Q48705470 |
| | Cholecystokinin decreases food intake in rats. | Q52320733 |
| | Cholecystokinin elicits Satiety in Rats with Open Gastric Fistulas | Q54170533 |
| | Localization of cannabinoid receptors CB1, CB2, GPR55, and PPARα in the canine gastrointestinal tract | Q56379613 |
| | Additive effects of cannabinoid CB1 receptors blockade and cholecystokinin on feeding inhibition | Q59620166 |
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cholecystokinin | Q60315441 |
| P304 | page(s) | e13927 | |
| P577 | publication date | 2018-12-01 | |
| P1433 | published in | Physiological Reports | Q15716763 |
| P1476 | title | Activity in nodose ganglia neurons after treatment with CP 55,940 and cholecystokinin | |
| P478 | volume | 6 | |